Early warning system for immunotherapy side effects
Part of Cancer clinical trials.
This study is for people with cancer who are already receiving immunotherapy (checkpoint inhibitors). It aims to build an early warning system to help detect and manage possible organ damage or other side effects from the treatment, using advanced testing to keep you safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer and are currently being treated with an immunotherapy drug called a checkpoint inhibitor.
- You do not have a serious autoimmune disease that is active right now.
- Your major organs (heart, lungs, liver, kidneys) are working well enough.
- You do not have an active infection that needs treatment.
- You are not pregnant or breastfeeding, and you are not allergic to the study drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial aims to improve how doctors spot and track side effects from immunotherapy. If you are on or have had immunotherapy, your experience can help build a better system for monitoring these treatments.
This study looks at how side effects happen in people receiving immune checkpoint inhibitor immunotherapy for solid cancers. It uses multiple types of tests to better understand these toxicities and may help improve safety and care in the future.
This study collects blood, stool, and tissue samples from people who have had side effects from immunotherapy (a type of cancer treatment that helps your immune system fight cancer). It aims to learn more about these side effects, so doctors can better manage them in the future.
This study looks for markers in the blood that might predict side effects from immune checkpoint inhibitor therapy. By identifying these markers, doctors may better manage or prevent side effects for future patients.
This study watches heart health in people starting immunotherapy (a cancer treatment that boosts the immune system) by checking blood samples for heart-related markers. It aims to find early signs of heart problems so they can be managed sooner.
This study is a registry that collects information on immune-related side effects in cancer patients receiving immunotherapy. It helps doctors understand and manage these side effects better.
Hear when a new Malignant Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.